Healthpeak Properties (NYSE:DOC) Rating Lowered to "Sell" at Wall Street Zen

Key Points

• Wall Street Zen downgraded Healthpeak Properties (NYSE:DOC) from a "hold" to a sell rating in a report issued Saturday.
• Despite the downgrade, the consensus remains Hold — five analysts rate Buy and nine rate Hold — with a consensus price target of $18.04.
• The REIT recently beat quarterly EPS estimates ($0.47 vs. $0.45), set FY2026 guidance of 1.700–1.740 EPS, and is trading around $16.44 with a market cap of $11.43 billion.

Healthpeak Properties (NYSE:DOC - Get Free Report) was downgraded by equities research analysts at Wall Street Zen from a "hold" rating to a "sell" rating in a report issued on Saturday.

A number of other equities research analysts have also commented on the stock. Weiss Ratings reaffirmed a "hold (c-)" rating on shares of Healthpeak Properties in a research note on Friday, April 24th. The Goldman Sachs Group initiated coverage on shares of Healthpeak Properties in a research note on Friday, January 9th. They set a "neutral" rating and a $17.00 target price on the stock. UBS Group initiated coverage on shares of Healthpeak Properties in a research note on Monday, April 20th. They set a "neutral" rating and a $17.00 target price on the stock. Scotiabank raised shares of Healthpeak Properties to a "hold" rating in a research note on Thursday, April 23rd. Finally, Morgan Stanley cut their target price on shares of Healthpeak Properties from $21.00 to $18.00 and set an "overweight" rating on the stock in a research note on Tuesday. Five analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. According to MarketBeat, Healthpeak Properties presently has a consensus rating of "Hold" and a consensus price target of $18.04.

Healthpeak Properties Trading Up 1.7%

NYSE:DOC opened at $16.44 on Friday. The firm's fifty day moving average is $16.94 and its 200-day moving average is $17.17. The company has a debt-to-equity ratio of 1.21, a quick ratio of 2.82 and a current ratio of 2.82. Healthpeak Properties has a 52 week low of $15.70 and a 52 week high of $19.68. The firm has a market cap of $11.43 billion, a P/E ratio of 164.42, a P/E/G ratio of 2.23 and a beta of 1.00.

Healthpeak Properties (NYSE:DOC - Get Free Report) last posted its quarterly earnings data on Monday, February 2nd. The real estate investment trust reported $0.47 EPS for the quarter, beating analysts' consensus estimates of $0.45 by $0.02. Healthpeak Properties had a net margin of 2.52% and a return on equity of 0.84%. The company had revenue of $719.40 million for the quarter, compared to analyst estimates of $685.14 million. During the same period in the prior year, the firm posted $0.46 EPS. The company's quarterly revenue was up 3.1% on a year-over-year basis. Healthpeak Properties has set its FY 2026 guidance at 1.700-1.740 EPS. Equities analysts expect that Healthpeak Properties will post 1.74 earnings per share for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of DOC. Norges Bank acquired a new position in Healthpeak Properties during the fourth quarter worth $153,550,000. JPMorgan Chase & Co. raised its holdings in Healthpeak Properties by 41.0% during the third quarter. JPMorgan Chase & Co. now owns 28,236,534 shares of the real estate investment trust's stock worth $540,730,000 after buying an additional 8,212,504 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in Healthpeak Properties by 694.6% during the third quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 8,016,692 shares of the real estate investment trust's stock worth $153,520,000 after buying an additional 7,007,777 shares during the last quarter. Fuller & Thaler Asset Management Inc. raised its holdings in Healthpeak Properties by 19.2% during the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 29,648,260 shares of the real estate investment trust's stock worth $476,744,000 after buying an additional 4,776,056 shares during the last quarter. Finally, Equity Investment Corp raised its holdings in Healthpeak Properties by 209.6% during the third quarter. Equity Investment Corp now owns 5,330,948 shares of the real estate investment trust's stock worth $102,088,000 after buying an additional 3,608,849 shares during the last quarter. Institutional investors and hedge funds own 93.57% of the company's stock.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.